GemPharmatech Co (688046.SS) Stock Price
GemPharmatech Co Price
Over the last 7 years GemPharmatech Co grew revenue by 47.1% annually, reaching 793.39 M CNY. Earnings per share have grown at 26.5% per year over the last 6 years. For GemPharmatech Co, the net margin of 18.0% is down versus 31.7% a few years ago. At today's price the dividend yield works out to roughly 0.08%. The payout ratio is around 9% of earnings. The consensus 12-month price target for GemPharmatech Co is 21.31 CNY, about 40.0% below where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.
GemPharmatech Co stock price
GemPharmatech Co business model & stock analysis
Frequently asked questions about GemPharmatech Co
Analysts currently set an average price target of 21.31 CNY for the GemPharmatech Co stock (median: 21.31 CNY), implying -40.0 % versus the latest price. The consensus is based on 6 analyst ratings.
6 analysts currently rate the GemPharmatech Co stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect GemPharmatech Co to generate revenue of 954.56 M CNY and earnings per share of 0.49 CNY.
Converted at the current exchange rate, the GemPharmatech Co share trades at 4.72 EUR (35.50 CNY).
The expected revenue of GemPharmatech Co is 954.56 M CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of GemPharmatech Co is 200.90 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of GemPharmatech Co is currently 72.45. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the GemPharmatech Co stock.
The price-to-sales ratio (P/S) of GemPharmatech Co is currently 15.25. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the GemPharmatech Co stock.
The Eulerpool Quality Score for GemPharmatech Co is 3/10.
The ISIN of GemPharmatech Co is CNE100005964. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of GemPharmatech Co is 688046.SS. The ticker symbol is used to trade GemPharmatech Co shares on the stock exchange.
GemPharmatech Co stock
GemPharmatech Co Peer Group
GemPharmatech Co FIGI
All fundamentals and in-depth analysis of GemPharmatech Co
Our stock analysis for GemPharmatech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GemPharmatech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.